ATE536360T1 - Neues nukleinsäuretransfersystem - Google Patents
Neues nukleinsäuretransfersystemInfo
- Publication number
- ATE536360T1 ATE536360T1 AT09761895T AT09761895T ATE536360T1 AT E536360 T1 ATE536360 T1 AT E536360T1 AT 09761895 T AT09761895 T AT 09761895T AT 09761895 T AT09761895 T AT 09761895T AT E536360 T1 ATE536360 T1 AT E536360T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acid
- transfer system
- acid transfer
- new nucleic
- hydrocarbon compound
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000002430 hydrocarbons Chemical class 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- YYGNTYWPHWGJRM-AAJYLUCBSA-N squalene group Chemical group CC(C)=CCC\C(\C)=C\CC\C(\C)=C\CC\C=C(/C)\CC\C=C(/C)\CCC=C(C)C YYGNTYWPHWGJRM-AAJYLUCBSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0853205A FR2931152B1 (fr) | 2008-05-16 | 2008-05-16 | Nouveau systeme de transfert d'acide nucleique |
| PCT/FR2009/050887 WO2009150344A1 (fr) | 2008-05-16 | 2009-05-14 | Nouveau systeme de transfert d'acide nucleique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE536360T1 true ATE536360T1 (de) | 2011-12-15 |
Family
ID=40029347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09761895T ATE536360T1 (de) | 2008-05-16 | 2009-05-14 | Neues nukleinsäuretransfersystem |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110184053A1 (de) |
| EP (1) | EP2297176B1 (de) |
| JP (1) | JP2011522523A (de) |
| CN (1) | CN102083847A (de) |
| AT (1) | ATE536360T1 (de) |
| CA (1) | CA2724516A1 (de) |
| FR (1) | FR2931152B1 (de) |
| WO (1) | WO2009150344A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2937537A1 (fr) | 2008-10-29 | 2010-04-30 | Centre Nat Rech Scient | Nanoparticules de statine |
| US9517476B2 (en) * | 2008-10-31 | 2016-12-13 | Hitachi Koki Co., Ltd. | Centrifuge with acceleration and deceleration time display |
| WO2013025008A1 (en) | 2011-08-12 | 2013-02-21 | Lg Electronics Inc. | Method for processing data associated with idle mode signaling reduction in a wireless communication system |
| FR2988092B1 (fr) | 2012-03-16 | 2014-04-25 | Centre Nat Rech Scient | Complexes de vitamine c, nanoparticules desdits complexes, procedes pour leur preparation, leurs compositions, leurs utilisations cosmetiques et procede de traitement cosmetique |
| FR3018820B1 (fr) * | 2014-03-20 | 2018-01-05 | Centre National De La Recherche Scientifique (Cnrs) | Inhibiteurs de stat5 et utilisation de ceux-ci |
| FR3110427B1 (fr) | 2020-05-20 | 2023-07-14 | Laboratoires Eriger | Conjugué terpenique de couplage |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02204489A (ja) * | 1989-02-02 | 1990-08-14 | Ajinomoto Co Inc | 易溶性2’,3’―ジデオキシイノシン、その製造法及び2’,3’―ジデオキシイノシン水性溶液の製造法 |
| AU2916292A (en) * | 1991-10-24 | 1993-05-21 | Isis Pharmaceuticals, Inc. | Derivatized oligonucleotides having improved uptake and other properties |
| US5489539A (en) * | 1994-01-10 | 1996-02-06 | Hughes Aircraft Company | Method of making quantum well structure with self-aligned gate |
| ATE236188T1 (de) * | 1997-01-24 | 2003-04-15 | Conpharma As | Gemcitabin-derivate |
| WO2000053207A1 (de) * | 1999-03-09 | 2000-09-14 | Ganomycin Gesellschaft Für Biomedizinische Forschung Mbh ; | Biologisch aktive verbindungen aus ganoderma pfeifferi dms 13239 |
| FR2808691B1 (fr) * | 2000-05-12 | 2005-06-24 | Coletica | Cyclodextrines substituees preferentiellement sur leur face primaire par des fonctions acide ou amine |
| US20040092428A1 (en) * | 2001-11-27 | 2004-05-13 | Hongming Chen | Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof |
| JP4527984B2 (ja) * | 2002-02-01 | 2010-08-18 | ライフ テクノロジーズ コーポレーション | 増強された効力を有するオリゴヌクレオチド組成物 |
| US8591951B2 (en) * | 2002-05-15 | 2013-11-26 | Joachim B. Kohn | Tri-block copolymers for nanosphere-based drug delivery |
| JP2006510656A (ja) * | 2002-12-11 | 2006-03-30 | チョン・クン・ダン・ファーマシューティカル・コーポレーション | 吸収されにくい極性薬物の経口用製剤 |
| EP1498120A1 (de) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Halbfeste Formulierung für die orale Verabreichung des Taxols |
| US20050100577A1 (en) * | 2003-11-10 | 2005-05-12 | Parker Theodore L. | Expandable medical device with beneficial agent matrix formed by a multi solvent system |
| FR2874016B1 (fr) * | 2004-06-30 | 2006-11-24 | Centre Nat Rech Scient Cnrse | Nanoparticules de derives de la gemcitabine |
| US7879361B2 (en) * | 2005-01-04 | 2011-02-01 | Gp Medical, Inc. | Nanoparticles for drug delivery |
| CN101346393B (zh) * | 2005-11-02 | 2015-07-22 | 普洛体维生物治疗公司 | 修饰的siRNA分子及其应用 |
| FR2937549B1 (fr) * | 2008-10-29 | 2011-04-01 | Centre Nat Rech Scient | Nanoparticules de derives beta-lactamine |
| FR2937537A1 (fr) * | 2008-10-29 | 2010-04-30 | Centre Nat Rech Scient | Nanoparticules de statine |
-
2008
- 2008-05-16 FR FR0853205A patent/FR2931152B1/fr not_active Expired - Fee Related
-
2009
- 2009-05-14 JP JP2011508984A patent/JP2011522523A/ja active Pending
- 2009-05-14 WO PCT/FR2009/050887 patent/WO2009150344A1/fr not_active Ceased
- 2009-05-14 US US12/992,872 patent/US20110184053A1/en not_active Abandoned
- 2009-05-14 CA CA2724516A patent/CA2724516A1/fr not_active Abandoned
- 2009-05-14 EP EP09761895A patent/EP2297176B1/de not_active Not-in-force
- 2009-05-14 AT AT09761895T patent/ATE536360T1/de active
- 2009-05-14 CN CN2009801247545A patent/CN102083847A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009150344A1 (fr) | 2009-12-17 |
| JP2011522523A (ja) | 2011-08-04 |
| EP2297176B1 (de) | 2011-12-07 |
| FR2931152A1 (fr) | 2009-11-20 |
| US20110184053A1 (en) | 2011-07-28 |
| FR2931152B1 (fr) | 2010-07-30 |
| CN102083847A (zh) | 2011-06-01 |
| EP2297176A1 (de) | 2011-03-23 |
| CA2724516A1 (fr) | 2009-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125421T1 (el) | Ριβονουκλεϊκα οξεα που περιεχουν ν1-μεθυλο- ψευδοουρακιλες και χρησεις αυτων | |
| EA201171325A1 (ru) | Нуклеиновые кислоты, связывающиеся с гепсидином | |
| MX346862B (es) | Secuencias consenso de envoltura de vih y método para usar las mismas. | |
| WO2010127304A3 (en) | Sequencing methods | |
| EP2631291A4 (de) | Nukleinsäuremoleküle zur induzierung einer rna-interferenz und verwendungen davon | |
| EP2207896A4 (de) | Nukleinsäureamplifikation | |
| IN2014CN02574A (de) | ||
| MX2010001490A (es) | Acidos nucleicos de enlace sdf-1 y uso de los mismos. | |
| CY1110860T1 (el) | Αναστροφη μεταγραφαση τελομερασης πτηνου | |
| EA201792626A1 (ru) | Композиции и способы для ингибирования экспрессии транстиретина | |
| EA200970580A1 (ru) | Таннат разагилина | |
| DE112007001307A5 (de) | Mikrobiologische Herstellung von 3-Hydroxyisobuttersäure | |
| IN2015DN02238A (de) | ||
| IN2012DN00403A (de) | ||
| NZ600183A (en) | Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means | |
| MY157531A (en) | Td probe and its uses | |
| DK2135949T3 (da) | MCP-1-bindende nukleinsyrer | |
| EP2315747A4 (de) | Verfahren und zusammensetzungen in verbindung mit synthetischen beta-1,6 glucosamin-oligosacchariden | |
| EP2169057A4 (de) | In milchsäurebakterium entstandene doppelstrang-rna | |
| ATE510923T1 (de) | Nukleinsäure | |
| ATE536360T1 (de) | Neues nukleinsäuretransfersystem | |
| BR112014016877A2 (pt) | ácidos nucleicos de ligação a c5a | |
| EP2740788A4 (de) | Werkzeug für mehrere nukleinsäure- amplifikationsreaktionen | |
| MX2010003109A (es) | Acidos nucleicos de enlace c5a. | |
| CY1124624T1 (el) | Μητρες οι οποιες περιεχουν εναν τροποποιημενο πολυσακχαριτη |